Understanding how to manage localized prostate cancer through active surveillance
Prostate cancer Active Surveillance Study (PASS) Cohort: Infrastructure Support for Cancer Research
This study is looking at over 2,100 men with localized prostate cancer who are monitoring their condition instead of starting treatment right away, to find out more about how the cancer progresses and what factors can help predict outcomes, so that doctors can offer better, personalized care in the future.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10691254 on NIH RePORTER |
What this research studies
This research focuses on the Prostate cancer Active Surveillance Study (PASS) cohort, which includes over 2,100 men with localized prostate cancer who have chosen active surveillance as their management strategy. The study collects extensive clinical and epidemiological data, as well as biological samples, to better understand the progression of prostate cancer and the factors that influence patient outcomes. By analyzing this data, researchers aim to identify biomarkers that can predict cancer progression and improve personalized treatment approaches for patients. The infrastructure supported by this grant will ensure that valuable data and specimens are available for ongoing and future research.
Who could benefit from this research
Good fit: Ideal candidates for this research are men diagnosed with clinically localized prostate cancer who have opted for active surveillance.
Not a fit: Patients with advanced prostate cancer or those who are not eligible for active surveillance may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved management strategies for men with localized prostate cancer, potentially reducing overtreatment and enhancing patient quality of life.
How similar studies have performed: Previous research has shown promise in using similar cohort studies to identify biomarkers and improve cancer management strategies.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Lin, Daniel W. — Fred Hutchinson Cancer Center
- Study coordinator: Lin, Daniel W.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.